Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
18.6M
-
Shares change
-
-2.66M
-
Total reported value, excl. options
-
$773M
-
Value change
-
-$21M
-
Put/Call ratio
-
3.71
-
Number of buys
-
76
-
Number of sells
-
-27
-
Price
-
$41.49
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2021
115 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q1 2021.
TransMedics Group, Inc. - Common Stock (TMDX) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.6M shares
of 33.9M outstanding shares and own 54.89% of the company stock.
Largest 10 shareholders include FMR LLC (3.9M shares), BlackRock Inc. (1.9M shares), CREDIT SUISSE AG/ (1.5M shares), VANGUARD GROUP INC (1.21M shares), Sandhill Capital Partners LLC (1.2M shares), MACQUARIE GROUP LTD (968K shares), KPCB XIII Associates, LLC (923K shares), Bellevue Group AG (742K shares), FEDERATED HERMES, INC. (605K shares), and EMERALD ADVISERS, LLC (605K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.